title: Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing.
abstract: Using a specially constructed questionnaire, the effect of BRCA test results for the Jewish founder mutations and genetic counseling on women's attitudes towards and acceptance of preventive surgeries was evaluated. The subjects consisted of 99 women 43% of whom were found to be carriers as opposed to 57%--non-carriers. After learning of their genetic status, 94% of the carriers and 28% of the non-carriers declared having positively considered the option of preventive oophorectomy. However, only about 25% of the carriers and 4.5% of the non-carriers had positively considered the option of preventive mastectomy. In practice, 78% of the carriers and 18% of the non-carriers who proved to be eligible for these procedures underwent preventive oophorectomy compared with 19% of carriers and 1.8% of non-carriers who underwent preventive mastectomy. Almost all carriers, as well as a majority of the non-carriers, who finally opted for the preventive surgeries did so after learning the result of their genetic test. The different attitudes toward the two surgeries were found to be based on varied beliefs regarding the two procedures. Preventive oophorectomy was perceived as being more acceptable to women than preventive mastectomy both from an attitudinal as well as practical aspect. These differences may be the result of cultural factors, of women's trust in the ability of screening tests to prevent morbidity and/or mortality, of the effect of the surgeries on body image and of different counseling protocols.
authors.affiliation: Department of Human Genetics, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.
authors.forename: Vardit
authors.initials: V
authors.lastname: Kram
authors.forename: Tamar
authors.initials: T
authors.lastname: Peretz
authors.forename: Michal
authors.initials: M
authors.lastname: Sagi
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006579:Heterozygote; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D009154:Mutation; D010051:Ovarian Neoplasms / Q000517:prevention & control*; D010052:Ovariectomy